| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |